Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model

Transfusion

Volumn 52, Issue 12, 2012, Pages 2631-2645

  Liepkalns, Justine S ^a,b   Hod, Eldad A ^a,b   Stowell, Sean R ^a,b   Cadwell, Chantel M ^a,b   Spitalnik, Steven L ^a,b   Zimring, James C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; COMPLEMENT COMPONENT C3; FC RECEPTOR; FLUORESCENT DYE; GLYCOPHORIN A; INTERLEUKIN 10; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BLOOD GROUP INCOMPATIBILITY; BLOOD SAMPLING; BLOOD TRANSFUSION REACTION; CELL ADHESION; CLEARANCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE STORM; DISEASE MODEL; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; INHIBITION KINETICS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SPLENECTOMY; WILD TYPE;

ANIMALS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; COMPLEMENT C3; CYTOKINES; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FLOW CYTOMETRY; GLYCOPHORIN; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTORS, IGG; SPLEEN; SPLENECTOMY;

EID: 84870978564     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03647.x     Document Type: Article

References (48)

1. Zimring JC, Spitalnik SL,. Alloimmunization to red cell antigens and management of alloimmunized patients. In:, Mintz PD, editor. Transfusion therapy clinical principles and practice. Bethesda (MD): American Association of Blood Banks; 2011. p. 631-42.
2. Davenport RD,. Management of transfusion reactions. In:, Mintz PD, editor. Transfusion therapy clinical principles and practice. Bethesda (MD): American Association of Blood Banks; 2011. p. 757-84.
3. Vamvakas EC, Blajchman MA,. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
4. Linden JV, Paul B, Dressler KP,. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601-6.
5. McClelland DB, Phillips P,. Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ 1994; 308: 1205-6.
6. Bowman J,. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997; 21: 39-44.
7. Gehrs BC, Friedberg RC,. Autoimmune hemolytic anemia. Am J Hematol 2002; 69: 258-71.
8. Engelfriet CP,. The immune destruction of red cells. Transfus Med 1992; 2: 1-6.
9. Schreiber AD, Frank MM,. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest 1972; 51: 575-82.
10. Schreiber AD, Frank MM,. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J Clin Invest 1972; 51: 583-9.
11. Petz LD, Garratty G,. Immune hemolytic anemias. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2004.
12. Attanasio P, Shumilina E, Hermle T, Kiedaisch V, Lang PA, Huber SM, Wieder T, Lang F,. Stimulation of eryptosis by anti-A IgG antibodies. Cell Physiol Biochem 2007; 20: 591-600.
13. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F,. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009; 49: 1785-92.
14. Brain MC, Pihl C, Robertson L, Brown CB,. Evidence for a mechanosensitive calcium influx into red cells. Blood Cells Mol Dis 2004; 32: 349-52.
15. Brain M, Ruether B, Valentine K, Brown C, ter Keurs H,. Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Transfusion 2010; 50: 292-301.
16. Chadebech P, Michel M, Janvier D, Yamada K, Copie-Bergman C, Bodivit G, Bensussan A, Fournie JJ, Godeau B, Bierling P, Izui S, Noizat-Pirenne F,. IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and Fc alpha RI. Blood 2010; 116: 4141-7.
17. Shibata T, Berney T, Reininger L, Chicheportiche Y, Ozaki S, Shirai T, Izui S,. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms. Int Immunol 1990; 2: 1133-41.
18. Bigbee WL, Langlois RG, Vanderlaan M, Jensen RH,. Binding specificities of eight monoclonal antibodies to human glycophorin A-studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNV-type chimpanzee erythrocytes. J Immunol 1984; 133: 3149-55.
19. Bigbee WL, Vanderlaan M, Fong SS, Jensen RH,. Monoclonal antibodies specific for the M- and N-forms of human glycophorin A. Mol Immunol 1983; 20: 1353-62.
20. Blackall DP, Ugorski M, Pahlsson P, Shakin-Eshleman SH, Spitalnik SL,. A molecular biologic approach to study the fine specificity of antibodies directed to the MN human blood group antigens. J Immunol 1994; 152: 2241-7.
21. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT, Overbeek PA,. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A 1991; 88: 2065-9.
22. Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA,. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001; 97: 2872-8.
23. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC,. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009; 114: 2315-22.
24. Wasniowska K, Lisowska E, Halverson GR, Chaudhuri A, Reid ME,. The Fya, Fy6 and Fy3 epitopes of the Duffy blood group system recognized by new monoclonal antibodies: identification of a linear Fy3 epitope. Br J Haematol 2004; 124: 118-22.
25. Unkeless JC,. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580-96.
26. Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL,. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007; 109: 3099-107.
27. Gilson CR, Zimring JC,. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model. Transfusion 2012; 52: 849-59.
28. Hendrickson JE, Hod EA, Cadwell CM, Eisenbarth SC, Spiegel DA, Tormey CA, Spitalnik SL, Zimring JC,. Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. Transfusion 2011; 51: 2445-54.
29. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD,. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005; 106: 1105-12.
30. Gros P, Milder FJ, Janssen BJ,. Complement driven by conformational changes. Nat Rev Immunol 2008; 8: 48-58.
31. Linton S,. Animal models of inherited complement deficiency. Mol Biotechnol 2001; 18: 135-48.
32. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV,. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994; 76: 519-29.
33. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV,. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005; 23: 41-51.
34. Kurlander RJ, Ellison DM, Hall J,. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol 1984; 133: 855-62.
35. Bonnerot C, Daeron M,. Biological activities of murine low-affinity Fc receptors for IgG. Immunomethods 1994; 4: 41-7.
36. Delemarre FG, Kors N, Kraal G, van Rooijen N,. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J Leukoc Biol 1990; 47: 251-7.
37. Miller MR, Thompson WR, Casella JF, Spevak PJ,. Antibody-mediated red blood cell agglutination resulting in spontaneous echocardiographic contrast. Pediatr Cardiol 1999; 20: 287-9.
38. Waterbury L, Parnes H, Katz RS,. Fatal warm antibody autoimmune hemolysis with marked erythrocyte autoagglutination and liver necrosis. South Med J 1986; 79: 646-7.
39. Cutbush M, Mollison PL,. Relation between characteristics of blood-group antibodies in vitro and associated patterns of red cell destruction in vivo. Br J Haematol 1958; 4: 115-37.
40. Cutbush M,. Observations on the antihuman globulin test. Bibl Haematol 1958; 7: 185-9.
41. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA,. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12: 682-7.
42. Garratty G,. A new mechanism for immune destruction of red blood cells? Transfusion 2010; 50: 274-7.
43. NIH conference. Pathophysiology of immune hemolytic anemia. Ann Intern Med 1977; 87: 210-22.
44. Jandl JH, Kaplan ME,. The destruction of red cells by antibodies in man. III. Quantitative factors influencing the patterns of hemolysis in vivo. J Clin Invest 1960; 39: 1145-56.
45. Jones NC, Mollison PL, Veall N,. Removal of incompatible red cells by the spleen. Br J Haematol 1957; 3: 125-33.
46. Meite M, Leonard S, Idrissi ME, Izui S, Masson PL, Coutelier JP,. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol 2000; 74: 6045-9.
47. Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD,. Blood banking and transfusion medicine. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2007.
48. Miescher S, Spycher MO, Amstutz H, De Haas M, Kleijer M, Kalus UJ, Radtke H, Hubsch A, Andresen I, Martin RM, Bichler J,. A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes. Blood 2004; 103: 4028-35.